Prevention of host-to-host transmission by SARS-CoV-2 vaccines.

Mostaghimi, Darius; Valdez, Caroline N; Larson, Haleigh T; Kalinich, Chaney C; Iwasaki, Akiko

Mostaghimi, Darius; Valdez, Caroline N; Larson, Haleigh T; Kalinich, Chaney C; Iwasaki, Akiko.

Afiliação

Mostaghimi D; Department of Immunobiology, New Haven, CT, USA; Yale University School of Medicine, New Haven, CT, USA.
Valdez CN; Yale University School of Medicine, New Haven, CT, USA.
Larson HT; Yale University School of Medicine, New Haven, CT, USA; Department of Cardiac Surgery, Yale New Haven Hospital, New Haven, CT, USA.
Kalinich CC; Yale University School of Medicine, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA.
Iwasaki A; Department of Immunobiology, New Haven, CT, USA; Yale University School of Medicine, New Haven, CT, USA; Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA; Howard Hughes Medical Institute, Chevy Chase, MD, USA. Electronic address: akiko.iwasaki@yale.e

Lancet Infect Dis ; 22(2): e52-e58, 2022 02.

Article em En | MEDLINE | ID: mdl-34534512

Assuntos

Vacinas contra COVID-19; COVID-19/prevenção & controle; COVID-19/transmissão; Anticorpos Antivirais/biossíntese; Anticorpos Antivirais/imunologia; Vacinas contra COVID-19/efeitos adversos; Vacinas contra COVID-19/imunologia; Humanos; Imunoglobulina A/biossíntese; Imunoglobulina A/imunologia; Imunoglobulina G/biossíntese; Imunoglobulina G/imunologia; Replicação Viral/imunologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Vacinas contra COVID-19 / COVID-19 Tipo de estudo: Clinical_trials / Observational_studies Limite: Humans Idioma: En Revista: Lancet Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google